An Open-Label, Long-Term Safety Study of SD-809 (Dutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Auspex Pharmaceuticals, Inc.
Start Date
October 1, 2014
End Date
July 8, 2015
Administered By
Neurology, Movement Disorders
Awarded By
Auspex Pharmaceuticals, Inc.
Start Date
October 1, 2014
End Date
July 8, 2015